ADVANCES IN THERAPEUTICS - CONVERTING ENZYME-INHIBITION AND THE KIDNEY

被引：6

作者：

HOLLENBERG, NK

机构：

[1] BRIGHAM & WOMENS HOSP, DEPT RADIOL, BOSTON, MA 02115 USA

[2] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA

来源：

AMERICAN JOURNAL OF MEDICINE | 1985年 / 79卷 / 3C期

关键词：

D O I：

10.1016/0002-9343(85)90072-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1 / 2

页数：2

共 9 条

[1] RENAL RESPONSE TO CAPTOPRIL IN SEVERE HEART-FAILURE - ROLE OF FUROSEMIDE IN NATRIURESIS AND REVERSAL OF HYPONATREMIA [J].

DZAU, VJ ;

HOLLENBERG, NK .

ANNALS OF INTERNAL MEDICINE, 1984, 100 (06) :777-782

[2] VASOCONSTRICTION-VOLUME ANALYSIS FOR UNDERSTANDING AND TREATING HYPERTENSION - USE OF RENIN AND ALDOSTERONE PROFILES [J].

LARAGH, JH .

AMERICAN JOURNAL OF MEDICINE, 1973, 55 (03) :261-274

[3] CORRECTION OF DILUTIONAL HYPONATREMIA IN SEVERE CHRONIC HEART-FAILURE BY CONVERTING-ENZYME INHIBITION [J].

PACKER, M ;

MEDINA, N ;

YUSHAK, M .

ANNALS OF INTERNAL MEDICINE, 1984, 100 (06) :782-789

[4] CAPTOPRIL - AN UPDATE REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN CONGESTIVE HEART-FAILURE [J].

ROMANKIEWICZ, JA ;

BROGDEN, RN ;

HEEL, RC ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1983, 25 (01) :6-40

[5] HYPERTENSIVE CRISIS IN SYSTEMIC-SCLEROSIS - TREATMENT WITH THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421 (ENALAPRIL) IN CAPTOPRIL-INTOLERANT PATIENTS [J].

SMITH, CD ;

SMITH, RD ;

KORN, JH .

ARTHRITIS AND RHEUMATISM, 1984, 27 (07) :826-828

[6]

SMITH WM, 1984, HYPERTENSION ANGIOTE, P261

[7] CAPTOPRIL IN THE TREATMENT OF SCLERODERMA RENAL CRISIS [J].

THURM, RH ;

ALEXANDER, JC .

ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (04) :733-735

[8]

WEINBERGER MH, 1982, BRIT J CLIN PHARMACO, V14, pS127, DOI 10.1111/j.1365-2125.1982.tb02069.x

[9]

1982, BR J CLIN PHARM, V14, pS97

← 1 →